If thyroid labs are optimized but symptoms such as weight gain, insulin resistance, or metabolic syndrome persist, a GLP-1 medication may be introduced to break through the plateau and support weight reduction
1 Ultimately, it can reduce treatment burden and improve patients quality of life by allowing self-administration
Most patients experience minimal discomfort, and there is no downtime afterward
The campaigns Find Your +2 theme highlights APLBs core principle: combining the right active ingredients with the right technology for maximum results
Given that our data show that more than half the patients taking GLP-1 medications earn less than $40,000 per year, this presents a financial challenge
Neuropeptides (2018) 71:7080